Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Sep 17, 2026
- Accession no.
- 0001106578-26-000143
- Filed
- Sep 17, 2026, 4:43 PM ET
- Trade date
- Sep 16, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.76M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $117.76 | +$1,118,720 | 333,943 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −2,080 | $498.45F3 | −$1,036,777.04 | 331,863 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −1,220 | $499.15F4 | −$608,966.42 | 330,643 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −492 | $500.19F5 | −$246,095.69 | 330,151 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −708 | $501.52F6 | −$355,076.58 | 329,443 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −2,160 | $502.44F7 | −$1,085,271.7 | 327,283 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −1,538 | $503.53F8 | −$774,428.99 | 325,745 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −1,182 | $504.17F9 | −$595,931.78 | 324,563 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −120 | $505.20F10 | −$60,624 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 423,410 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $497.69 to $498.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $498.71 to $499.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $499.95 to $500.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $500.95 to $501.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $501.97 to $502.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $502.97 to $503.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $503.97 to $504.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $505.08 to $505.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.